IRIS
Denti, Michela Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.713
AS - Asia 2.379
EU - Europa 2.348
SA - Sud America 432
AF - Africa 39
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.920
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.603
SG - Singapore 1.292
CN - Cina 613
RU - Federazione Russa 435
BR - Brasile 378
UA - Ucraina 324
IT - Italia 317
SE - Svezia 294
FI - Finlandia 240
GB - Regno Unito 203
VN - Vietnam 196
DE - Germania 163
LV - Lettonia 126
CA - Canada 69
NL - Olanda 51
BG - Bulgaria 50
IN - India 39
ES - Italia 30
FR - Francia 30
ID - Indonesia 29
JO - Giordania 29
MX - Messico 22
TR - Turchia 22
HK - Hong Kong 20
AR - Argentina 19
IQ - Iraq 19
IR - Iran 19
ZA - Sudafrica 19
JP - Giappone 18
PL - Polonia 18
AT - Austria 16
BD - Bangladesh 14
MY - Malesia 14
VE - Venezuela 12
PK - Pakistan 9
LT - Lituania 8
UZ - Uzbekistan 7
BE - Belgio 6
CH - Svizzera 6
CL - Cile 6
EC - Ecuador 6
IE - Irlanda 6
JM - Giamaica 6
SA - Arabia Saudita 6
AU - Australia 5
RO - Romania 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
KE - Kenya 4
KR - Corea 4
MA - Marocco 4
UY - Uruguay 4
CO - Colombia 3
DO - Repubblica Dominicana 3
GR - Grecia 3
HR - Croazia 3
IL - Israele 3
NP - Nepal 3
PT - Portogallo 3
AL - Albania 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
GE - Georgia 2
GT - Guatemala 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NI - Nicaragua 2
NO - Norvegia 2
PE - Perù 2
PH - Filippine 2
PS - Palestinian Territory 2
PY - Paraguay 2
RS - Serbia 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
HN - Honduras 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
NC - Nuova Caledonia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
QA - Qatar 1
SN - Senegal 1
TH - Thailandia 1
Totale 12.920
Salva come PNG Salva come JPEG
Città #
Chandler 832
Singapore 819
Ashburn 751
Jacksonville 676
Fairfield 648
Dallas 343
Woodbridge 322
Wilmington 275
Seattle 266
Houston 261
Santa Clara 250
Ann Arbor 240
Columbus 237
San Mateo 234
Cambridge 213
Princeton 207
Moscow 195
Beijing 170
Riga 126
New York 116
Helsinki 112
Los Angeles 93
Dearborn 80
Trento 74
Boardman 71
Hefei 61
Buffalo 58
The Dalles 58
Munich 49
San Diego 48
São Paulo 47
Sofia 46
Ho Chi Minh City 44
North Bergen 41
Bremen 36
London 35
Council Bluffs 34
Fremont 34
Hanoi 34
Dong Ket 31
Delft 28
Lawrence 28
Ottawa 26
Chicago 25
Jakarta 24
Rome 22
Como 21
Phoenix 20
Denver 19
Hong Kong 19
Norwalk 19
Lappeenranta 18
Milan 17
Poplar 17
Redondo Beach 17
San Paolo di Civitate 17
Warsaw 17
Brooklyn 16
Stockholm 16
Toronto 16
Tehran 15
Johannesburg 14
Nuremberg 14
Tokyo 14
Belo Horizonte 13
Guangzhou 13
Izmir 13
Orem 13
Des Moines 12
Atlanta 11
Chennai 11
Kilburn 11
San Jose 11
Badajoz 10
Boston 10
Frankfurt am Main 10
Ipoh 10
Salt Lake City 10
Shanghai 10
Verona 10
Washington 10
Falkenstein 9
Kunming 9
Montreal 9
Rio de Janeiro 9
Turku 9
Vienna 9
Baghdad 8
Costa Mesa 8
Elk Grove Village 8
Mexico City 8
Nanjing 8
San Francisco 8
Augusta 7
Da Nang 7
Düsseldorf 7
Recife 7
Shenyang 7
Tashkent 7
Tianjin 7
Totale 9.065
Salva come PNG Salva come JPEG
Nome #
The short-term impact of probiotic consumption on the oral cavity microbiome 246
The miR-15/107 Family of microRNA Genes Regulates CDK5R1/p35 with Implications for Alzheimer’s Disease Pathogenesis 204
A Cross-Platform Comparison of Affymetrix and Agilent Microarrays Reveals Discordant miRNA Expression in Lung Tumors of c-Raf Transgenic Mice 191
Double-target Antisense U1snRNAs Correct Mis-splicing Due to c.639+861C>T and c.639+919G>A GLA Deep Intronic Mutations 183
Statistical analysis of a Bayesian classifier based on the expression of miRNAs 181
Selection of reference genes is critical for miRNA expression analysis in human cardiac tissue. A focus on atrial fibrillation 179
Enhanced microbial diversity in the saliva microbiome induced by short-term probiotic intake revealed by 16S rRNA sequencing on the IonTorrent PGM platform 175
RNA intereference mediated therapy for neurodegenerative diseases 170
Reduced miR-659-3p levels correlate with progranulin increase in hypoxic conditions: Implications for frontotemporal dementia 170
DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells 170
An electroporation protocol for efficient DNA transfection in PC12 cells 165
MicroRNA-based, p53 dependent post-transcriptional circuits: mechanisms, targets and inter-individual variation 162
Plasma microRNA profiling distinguishes patients with frontotemporal dementia from healthy subjects 162
microRNAs make the call in cancer personalized medicine 159
A network in FrontoTemporal Dementia - an RNA perspective 157
A new splicing isoform of Cacna2d4 mimicking the effects of c.2451insC mutation in the retina: Novel molecular and electrophysiological insights 156
A novel RNA-binding protein from Triturus carnifex identified by RNA-ligand screening with the newt hammerhead ribozyme 154
Delivery is key: Lessons learnt from developing splice-switching antisense therapies 153
Oligonucleotide therapy 149
New Platform for the Direct Profiling of microRNAs in Biofluids 148
AAV-Mediated Allele-Specific RNA Interference of a Common Dominant Rhodopsin Mutation Causing Retinitis Pigmentosa 146
Splicing-correcting therapeutic approaches for retinal dystrophies: where endogenous gene regulation and specificity matter. 146
MicroRNA-based, p53 dependent post-transcriptional circuits: mechanisms, targets and inter-individual variation 143
Exon-Skipping Antisense Oligonucleotides to Correct Missplicing in Neurogenetic Diseases 142
A new vector, based on the polII promoter of U1 snRNA gene, for the expression of siRNAs in mammalian cells 141
miR-205 expression levels in non-small cell lung cancer do not always distinguish adenocarcinomas from squamous cell carcinomas. 141
A chimeric adeno-associated virus/antisense-U1small nuclear RNA effectively rescues dystrophin synthesis and muscle function by local treatment of mdx mice 139
Antisense RNA-mediated exon skipping in gene therapy 139
MiRNA-QC-and-Diagnosis: An R package for diagnosis based on MiRNA expression 139
AAV-mediated Allele-specific RNA interference of a common dominant Rhodopsin mutation causing Retinitis Pigmentosa 137
MicroRNAs in epithelial ovarian cancer 136
Upregulation of miR-133b and miR-328 in Patients With Atrial Dilatation: Implications for Stretch-Induced Atrial Fibrillation 136
miR375-3p Distinguishes Low-Grade Neuroendocrine From Non-neuroendocrine Lung Tumors in FFPE Samples 135
DNMT3A epigenetically regulates key microRNAs involved in epithelial-to-mesenchymal transition in prostate cancer 134
Long term benefit of AAV/antisense-mediated exon skipping in dystrophic mice 129
A loxP-containing pol II promoter for RNA interference is reversibly regulated by Cre recombinase 128
Circulating miR-127-3p as a potential biomarker for differential diagnosis in frontotemporal dementia 128
Long-term benefit of adeno-associated virus/antisense-mediated exon skipping in dystrophic mice 126
MicroRNAs as lung cancer biomarkers 124
Identification of new p53 target microRNAs by bioinformatics and functional analysis 124
Antisense RNA -induced exon-skipping for the gene therapy of Frontotemporal Dementia and Parkinsonism 123
Functional analysis of miRNAs involved in the regulation of the transcription factors Hoxa9, Hoxa10, Hoxa11 and Pax8 in epithelial ovarian cancer 121
Circulating microRNAs in Neurodegenerative Diseases 121
Comparison of different methods to extract RNA from cardiac tissue for miRNA profiling by qRT-PCR 121
Antisense RNA-induced exon-skipping for the gene therapy of frontotemporal dementia and parkinsonism associated with chromosome 17 (ftdp-17) 119
microRNA-375 expression distinguishes neuroendocrine from non-neuroendocrine lung tumours in FFPE samples 119
Antisense RNA -induced exon-skipping for the gene therapy of Frontotemporal Dementia and Parkinsonism 118
71 nucleotides from the terminal right part of PSTVd is the sufficient minimum of RNA capable of sustaining specific binding to tomato protein Virp1 114
A study on the newt hammerhead ribozyme : association to RNA-binding proteins and intracellular localisation 114
Circulating miRNAs as Biomarkers for Neurodegenerative Disorders 114
A study on the newt hammerhead ribozyme : association to RNA-binding proteins and intracellular localisation 112
MicroRNA and Lung Cancer 112
A vector for siRNA expression in mammalian cells that relies on polII-dependent transcription and produces asymmetric accumulation of one siRNA strand 111
Measurements methods for the development of microRNA-based tests for cancer diagnosis 109
Heterogeneity of Large Cell Carcinoma of the Lung: An Immunophenotypic and miRNA-Based Analysis. 108
Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model 106
Analisi della struttura e dell¿attivit¿ autocatalitica di trascritti dimerici ¿BglII¿ in Triturus 105
Short interfering RNAs specific for potato spindle tuber viroid are found in the cytoplasm but not in the nucleus 105
Delivery of oligonucleotide-based therapeutics: challenges and opportunities 105
mRNA fate: Life and death of the mRNA in the cytoplasm 103
Characterization of the RNA motif responsible for the specific interaction of potato spindle tuber viroid RNA (PSTVd) and the tomato protein Virp1 101
Il ribozima di tritone: struttura ed applicazioni 98
PMP70 knock-down generates oxidative stress and pro-inflammatory cytokine production in C6 glial cells 97
Replicating potato spindle tuber viroid RNA is accompanied by short RNA fragments that are characteristic of post-transcriptional gene silencing 97
RNAi-mediated silencing of ABCD3 gene expression in rat C6 glial cells: a model system to study PMP70 function 95
MIR-NATs repress MAPT translation and aid proteostasis in neurodegeneration 94
Small RNA molecules of great utility as diagnostic biomarkers in lung cancer 93
Fabry Disease: Antisense Therapeutics for intronic variations causing mis-spliced messenger RNA and active-site-specific chaperones (ASSC) for conformational enzyme defects 93
New circuits between miRNAs and transcription factors Hoxa9, Hoxa10, Hoxa11 and Pax8: possible identification of therapeutic targets for epithelial ovarian cancer treatment 93
Circulating cell-free microRNAs as biomarkers for neurodegenerative diseases 93
Preferential silencing of a common dominant rhodopsin mutation does not inhibit retinal degeneration in a transgenic model 90
Characterization of the RNA motif responsible for the specific interaction of potato spindle tuber viroid RNA (PSTVd) and the tomato protein Virp1 88
Uso di un ribozima di vertebrati per l'inattivazione del gene MGMT in cellule CHO 86
Virp1 is a host protein with a major role in potato spindle tuber viroid infection in Nicotiana plants 85
AAV-mediated retinal gene transfer in animal models of retinal degeneration 83
MicroRNAs in epithelial ovarian cancer 83
The newt hammerhead ribozyme: structure and applications 83
Integrative microRNAome analysis of skeletal muscle of Colossoma macropomum (tambaqui), Piaractus mesopotamicus (pacu), and the hybrid tambacu, based on next-generation sequencing data 83
Study on the affinity and specificity of the interaction between Potato Spindle Tuber viroid and tomato protein Virp1 82
Antisense RNA-mediated exon-skipping for gene therapy 81
Identification of the RNA binding domain of Virp-1 80
Exon Skipping Through Chimeric Antisense U1 snRNAs to Correct Retinitis Pigmentosa GTPase-Regulator (RPGR) Splice Defect 80
U1snRNA-mediated exon skipping for the therapy of Duchenne Muscular Dystrophy: towards a clinical trial 77
Towards functional analysis of BVRB, a gene encoding for a viroid binding protein 77
Exon-skipping mediated by the systemic delivery of AAV constructs expressing antisense-snRNAs restores dystrophin and muscular functionality in body-wide skeletal muscles of mdx mice 74
Characterisation of the protein components of the newt hammerhead ribozyme RNP 74
Replicating viroid RNA is accompanied by short RNA fragments that are characteristic of posttranscriptional gene silencing 74
Possible use of a naturally-occurring vertebrate hammerhead ribozyme to suppress human O-6-MGMT expression in CHO cells 74
Identification of miRNAs regulating MAPT expression and their analysis in plasma of patients with dementia 73
The motif in the Terminal Right Part of Potato Spindle Tuber Viroid is the determinant of specific in vitro recognition by tomato RNA-binding protein Virp1 72
La ribonucleoparticella del ribozima di tritone: fossile molecolare o una nuova particella coinvolta nel ¿processing¿ dell¿RNA? 72
Use of new RNA properties for gene therapy of HIV infections 71
Northwestern techniques for the analysis of RNA-protein interactions and the identification of RNA-binding proteins from cDNA expression libraries. 71
I ribozimi naturali 70
Blockade of Chloride Intracellular Ion Channel CLIC1 stimulates A-beta phagocytosis. 70
Virp1, a host factor necessary for replication of nuclear viroids 69
Body-wide rescue of dystrophin and muscle function in mdx mice by antisense-snRNAs mediated exon-skipping 69
Isolation of a novel ovary-specific RNA-binding protein by RNA-ligand screening with the newt hammerhead ribozyme 68
Caracterizaci¿n de la interacci¿n entre el viroide del tub¿rculo fusiforme de la patata (PSTVd) y la prote¿na de uni¿n a RNA viroidal X1 67
Associazione con proteine e localizzazione intracellulare del ribozima ¿hammerhead¿ di tritone 67
Totale 11.654
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.033
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 1.042
selected - selezionate 0
volume - volumi 3.217
Totale 60.292
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021805 0 0 0 0 0 117 84 55 185 72 192 100
2021/20221.284 57 238 5 72 89 25 46 202 75 125 103 247
2022/20231.714 239 198 26 266 191 257 7 117 238 12 76 87
2023/2024658 48 53 38 24 67 153 44 56 6 59 32 78
2024/20252.603 15 29 128 508 121 341 44 178 286 491 203 259
2025/20262.821 437 110 647 779 555 293 0 0 0 0 0 0
Totale 13.166